General Poster Session: Head and Neck Cancer
"May 18,1998" -- 1:00 PM to 5:00 PM -- Hall K
"Phase I/II evaluation of Targretin (LGD1069), a novel, RXR-specific retinoid, in patients with recurrent squamous cell carcinoma of the head and neck."
--------------------------------------------------------------
General Poster Session: Metastases and Advanced Breast Cancer
"May 19,1998" -- 8:00 AM to 12:00 PM -- Hall K
A phase I trial and pharmacokinetic study of 9-&cis&-retinoic acid (LGD 1057) and tamoxifen in metastatic breast cancer.
Lawrence, Julie -- National Cancer Inst
----------------------------------------------------------------
Poster Discussion Session: AIDS/ Psychosocial
"May 18,1998" -- 3:45 PM to 5:45 PM -- Room 304 ABC/ 305
Chair Freter, Carl -- Georgetown University Medical Center
Chair Scadden, David T. --
Oral LGD1057 is active in AIDS related Kaposi's sarcoma: an AIDS-associated Malignancy
Group trial (AMC-002).
Miles, Steven A -- UCLA Care Center
----------------------------------------------------------
General Poster Session: Clinical Pharmacology II
"May 18,1998" -- 1:00 PM to 5:00 PM -- Hall K
"A phase 1-2 trial of LGD1550, a novel rarselective retinoid, in advanced cancer patients."
Rizvi, Naiyer -- Georgetown University Medical Center
----------------------(same time as above and same bat place)-----------
Phase 1-2 study of a retinoic acid receptor-selective high-affinity ligand (LGD1550).
Soignet, Steven L -- Memorial Sloan-Kettering Cancer Ctr |
